POMDOCTOR Ltd (POM) Form 6-K — Oct 19, 2026

POMDOCTOR Limited announced it is terminating its ADR program and will list its Class A ordinary shares directly on Nasdaq, trading under the symbol POM beginning at the market open on October 21, 2026. Holders of ten ADSs will receive three Class A ordinary shares after a 10-to-1 share consolidation, and the deposit agreement with Citibank, N.A. terminates prior to the open on October 21. The change is structural only — it does not alter the underlying business — but holders should note the new CUSIP (G7166T112), the mandatory ADS cancellation, and the appointment of TranShare Corporation as U.S.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.